BMS-986458 features three stereocenters, one of which epimerizes easily, Mortensen said. The drug candidate, which would be ...

Gain Therapeutics, Inc. (Nasdaq: GANX) ("Gain", or the "Company"), a clinical-stage biotechnology company leading the discovery and development of the ...

The National Kidney Foundation (NKF) has awarded Jayme Locke, MD, MPH, FACS, FAST, Vice President, Medical Development, ...

Phase 1 MAD dosing completed for SION-451 and final MAD cohort of SION-719 planned; Interim data in healthy volunteers show potential to provide ...

Manchester United have confirmed plans to leave Old Trafford and move to a new 100,000-seater stadium. The new stadium, which will be the largest in the UK, will be built on club-owned land ...

M.D., Ph.D., President and Chief Executive Officer of Black Diamond Therapeutics. "Servier's commitment to innovation and deep expertise in oncology make it an ideal partner for Black Diamond as we ...

M.D., Ph.D., President and Chief Executive Officer of Black Diamond Therapeutics. “Servier’s commitment to innovation and deep expertise in oncology make it an ideal partner for Black Diamond as we ...

After raising an impressive 1.2 billion euros in 2024, European venture capital firm Sofinnova Partners is topping up its ...

This oversubscribed Series A funding round was led by General Catalyst with additional investment from new investors, British ...

Man Utd are to leave Old Trafford and move to a new 100,000-seater stadium; the stadium will take five years to build and will be the biggest in the UK; "If the government really gets behind this ...

Fate Therapeutics, Inc. (NASDAQ:FATE – Free Report) – Equities research analysts at Wedbush raised their Q1 2025 earnings per share (EPS) estimates for Fate Therapeutics in a research note ...